Bosutinib
(bah-SOO-tih-nib) This page contains brief information about bosutinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
| US Brand Name(s): |  | Bosulif |
| | ||
| | ||
| FDA Approved: | | Yes |
Bosutinib is approved to treat:
- Chronic myelogenous leukemia that is Philadelphia chromosome positive. It is used in patients who cannot be treated with or have not gotten better with other treatment.
Bosutinib is also being studied in the treatment of other types of cancer.
More About BosutinibDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Clinical Trials Accepting PatientsFind Clinical Trials for Bosutinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
Back to Top
